Immediate Impact
3 standout
Citing Papers
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
2024 Standout
The two sides of chromosomal instability: drivers and brakes in cancer
2024 Standout
Works of Baohui Han being referenced
Phase Ib/IIa study evaluating the safety and clinical activity of osimeritinib combined with anlotinib in EGFRm, treatment-naive advanced NSCLC patients (AUTOMAN).
2022
Final progression-free survival, interim overall survival, and biomarker analyses of CHOICE-01: A phase 3 study of toripalimab versus placebo in combination with first-line chemotherapy for advanced NSCLC without EGFR/ALK mutations.
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Baohui Han | 24 | 29 | 6 | 6 | 8 | 38 | |
| Jade M. van Berge Henegouwen | 17 | 25 | 10 | 5 | 12 | 36 | |
| Alain Gratet | 15 | 23 | 9 | 5 | 7 | 40 | |
| Juan J Lence | 8 | 20 | 4 | 7 | 9 | 43 | |
| Julie S. Deutsch | 20 | 24 | 4 | 5 | 8 | 38 | |
| Alisha Chou | 43 | 17 | 13 | 5 | 6 | 51 | |
| Meredith Faggen | 10 | 33 | 7 | 2 | 10 | 46 | |
| Mariusz Kwiatkowski | 31 | 37 | 4 | 14 | 9 | 48 | |
| Tomonori Hirano | 22 | 10 | 4 | 4 | 6 | 33 | |
| Qilong Zhang | 29 | 41 | 14 | 4 | 8 | 50 | |
| Lanie E. Happ | 9 | 18 | 8 | 11 | 9 | 40 |
All Works
Loading papers...